Quantum BioPharma announces annual general and special meeting of shareholders
QNTM•Quantum BioPharma will hold its annual general and special shareholder meeting on November 10, 2026, where shareholders will vote on a share consolidation at a maximum 10-for-1 ratio.
1. Meeting and vote
Shareholders will vote on consolidating class A multiple voting shares and class B subordinate voting shares at a maximum 10-for-1 ratio. The board would select the ratio and could abandon the consolidation without further shareholder approval. Fractions of one-half or less would round down, while fractions greater than one-half would round up.
